In Cox proportional hazards models in lung cancer, there were no significant differences in prior radiation therapy, histology (adenocarcinoma or squamous cell carcinoma), and prior epidermal growth factor receptor-tyrosine kinase inhibitor therapy (S5 Table). This evidence concerns the gene EGFR and lung carcinoma.